These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8443743)

  • 21. Loss of heterozygosity of the APC gene in oral squamous cell carcinoma.
    Rivero ER; Horta MC; Silva Guerra EN; Ferraz AR; Nunes FD
    Pathol Res Pract; 2008; 204(11):793-7. PubMed ID: 18617334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP.
    Chen YH; Li CD; Yap EP; McGee JO
    J Pathol; 1995 Oct; 177(2):129-34. PubMed ID: 7490678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity of APC and MCC genes in oral squamous cell carcinomas in Taiwan.
    Huang JS; Chiang CP; Kok SH; Kuo YS; Kuo MY
    J Oral Pathol Med; 1997 Aug; 26(7):322-6. PubMed ID: 9250932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
    J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13.
    Miyakawa A; Wang XL; Nakanishi H; Imai FL; Shiiba M; Miya T; Imai Y; Tanzawa H
    Int J Oncol; 1998 Oct; 13(4):705-9. PubMed ID: 9735399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP.
    Oliva MR; Saez GT; Latres E; Cordon-Cardo C
    Diagn Mol Pathol; 1995 Mar; 4(1):54-8. PubMed ID: 7735557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer.
    Uzawa K; Suzuki H; Komiya A; Nakanishi H; Ogawara K; Tanzawa H; Sato K
    Int J Cancer; 1996 Aug; 67(4):510-4. PubMed ID: 8759609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic alterations in thyroid tumor progression: association with p53 gene mutations.
    Ito T; Seyama T; Mizuno T; Tsuyama N; Hayashi Y; Dohi K; Nakamura N; Akiyama M
    Jpn J Cancer Res; 1993 May; 84(5):526-31. PubMed ID: 8100564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of codon 72 polymorphism of p53 gene from blood and loss of heterozygosity in brain tumors using polymerase chain reaction].
    Iijima J; Sawa H; Shiina Y; Hoshino T
    No To Shinkei; 1993 Jan; 45(1):43-7. PubMed ID: 8476653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas.
    Liao PH; Chang YC; Huang MF; Tai KW; Chou MY
    Oral Oncol; 2000 May; 36(3):272-6. PubMed ID: 10793330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidermoid carcinoma of the cervix uteri: molecular abnormalities of p53 and rb genes].
    Wistuba I; Capurro I
    Rev Med Chil; 1996 May; 124(5):553-60. PubMed ID: 9035506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines.
    Min BM; Baek JH; Shin KH; Gujuluva CN; Cherrick HM; Park NH
    Eur J Cancer B Oral Oncol; 1994 Sep; 30B(5):338-45. PubMed ID: 7703804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of p53 gene as a biomarker of high risk oral leukoplakias.
    Saranath D; Tandle AT; Deo MG; Mehta AR; Sanghvi V
    Indian J Biochem Biophys; 1997 Jun; 34(3):266-73. PubMed ID: 9425746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
    Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.